Febuxostat Tablet
Product Images NDC 59651-113

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Febuxostat (NDC 59651-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel (40 mg (30 Tablets Bottle))

Label for Febuxostat 40 mg tablets by Aurobindo Pharma Limited. The label indicates each film-coated tablet contains 40 mg of febuxostat. It includes directions to see the package insert for dosage, storage instructions (20° to 25°C, protect from light), and a note to not accept if the bottle seal is broken. The package contains 30 tablets and is distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label.principal Display Panel (80 mg (30 Tablets Bottle))

Label for Febuxostat Tablets 80 mg oral tablets, containing 30 tablets per container. Labeled with the NDC 59651-114-30 and distributed by Aurobindo Pharma USA, Inc. The label includes storage instructions, dosage guidance to see package insert, and a warning not to accept if the bottle seal is broken. Made in India by Aurobindo Pharma Limited.*

FDA Label Image

Chemical Structure (Febuxostat Str)

Chemical structure of the active ingredient Febuxostat, showing its molecular arrangement including a benzene ring, thiazole ring, and associated functional groups such as a nitrile, carboxylic acid, and an ether linkage with an isobutyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.